Introductory text
United Kingdom
Commission Decision
of 30 June 2009
appointing members of the Committee for Orphan Medicinal Products
(Text with EEA relevance)
(2009/506/EC)
THE COMMISSION OF THE EUROPEAN COMMUNITIES,
Having regard to the Treaty establishing the European Community,
Having regard to the Regulation (EC) No 141/2000 of the European Parliament and of the Council of 16 December 1999 on orphan medicinal productsf1, and in particular Article 4(3) thereof,
Having regard to the recommendation of the European Medicines Agency of 3 April 2009,
Whereas:
(1)
The term of office of four members of the Committee for Orphan Medicinal Products, hereinafter ‘the Committee’, set up in accordance with Article 4 of Regulation (EC) No 141/2000, expired on 15 April 2009. One member of the Committee whose term of office expired was appointed by the Commission on the basis of a recommendation from the European Medicines Agency. Three other members whose term of office expired were appointed by the Commission to represent patients organisations. It is necessary, therefore, to appoint four members to the Committee.
(2)
The European Medicines Agency has recommended one person for nomination.
(3)
The members of the Committee should be appointed for a period of three years starting on 1 July 2009,
HAS DECIDED AS FOLLOWS: